<DOC>
	<DOCNO>NCT00679055</DOCNO>
	<brief_summary>A 12-Week Efficacy Study participant Peripheral Arterial Disease . primary hypothesis MK-0736 7 mg administer daily 12 week result decrease low extremity atherosclerotic plaque macrophage content compare placebo ( approximate decrease 30 % expect ) .</brief_summary>
	<brief_title>A Study How MK-0736 Affects Arterial Plaque ( 0736-006 ) ( TERMINATED )</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Participants peripheral arterial disease Participants must 18 85 year age Females must postmenopausal sterile Participans hepatic , HIV , endocrine , connective tissue , psychiatric disorder uncontrolled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>